<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>International Journal of Preventive Medicine (Int J Prev Med)</JournalTitle><Issn>2008-7802</Issn><Volume>10</Volume><Issue>1</Issue><PubDate PubStatus="epublish"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></Journal><title locale="en_US">Effect of Vitamin D on Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Clinical Trials</title><FirstPage>2008</FirstPage><LastPage>7802</LastPage><Language>EN</Language><AuthorList><Author><affiliation locale="en_US">Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur</affiliation></Author><Author><affiliation locale="en_US">Student Research Committee, Neyshabur&#13;
University of Medical Sciences, Neyshabur,</affiliation></Author></AuthorList><History><PubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>23</Day></PubDate></History><abstract locale="en_US">&lt;p&gt;&lt;span class="fontstyle0"&gt;New evidence suggests that low serum Vitamin D may cause nonalcoholic fatty liver disease (NAFLD). Hypovitaminosis D is associated with the severity and incidence of NAFLD. The objective of this study was to conduct a systematic review on randomized controlled trials (RCTs) assessing the effect of Vitamin D on serum metabolic profle among NAFLD patients. Databases including PubMed, Institute for Scientifc Information Web of Science, Scopus, and Google Scholar were searched up to November 2016. RCTs which studied Vitamin D effect on metabolic profles and liver function, and conducted among adults were included. Six articles were eligible&lt;br /&gt;to be considered in this systematic review. According to the result, Vitamin D supplementation might improve lipid profle and inﬂammatory mediators when compared with placebo. No article indicated signifcant effect of Vitamin D on liver enzymes except one article which revealed that&lt;br /&gt;Vitamin D together with calcium carbonate can reduce liver enzymes. Vitamin D supplementation may not improve anthropometric measures and glycemic index variables among patients with NAFLD. Vitamin D supplement might improve NAFLD symptoms, especially inﬂammatory&lt;br /&gt;mediators. More RCTs in different parts of world with different forms and doses of Vitamin D are necessary.&lt;br /&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;&lt;span class="fontstyle2"&gt;&lt;strong&gt;Keywords&lt;/strong&gt;: &lt;/span&gt;&lt;span class="fontstyle3"&gt;Nonalcoholic fatty liver disease, systematic review, Vitamin D&lt;/span&gt;&lt;/p&gt;</abstract><web_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/view/2001</web_url><pdf_url>http://ijpm.mui.ac.ir/index.php/ijpm/article/download/2001/717717821</pdf_url></Article></Articles>
